Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Goldstein

Showing results (131-140 of 234) with videos related to

Pageof 24
Sort By:
Msystems|March 17, 2021
Patient and Microbial Genomic Factors Associated with Carbapenem-Resistant Klebsiella pneumoniae Extraintestinal Colonization and InfectionZena Lapp, Jennifer H Han, Jenna Wiens, et al.
The American Journal of Gastroenterology|January 12, 2022
Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?Lynne V McFarland, Ravina Kullar, Stuart Johnson, et al.
International Journal of Antimicrobial Agents|August 1, 2006
In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodensC Vreni Merriam, Diane M Citron, Kerin L Tyrrell, et al.
Journal of Clinical Microbiology|June 28, 2013
Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samplesKerin L Tyrrell, Diane M Citron, Eliza S Leoncio, et al.
Anaerobe|October 8, 2016
The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenemsEllie J C Goldstein, Diane M Citron, Kerin L Tyrrell, et al.
Journal of Medical Microbiology|March 20, 2008
Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureusEllie J C Goldstein, Diane M Citron, Yumi A Warren, et al.
Oral Microbiology and Immunology|October 2, 2002
Sequence conservation and distribution of the fusobacterial immunosuppressive protein gene, fipAS Hunt Gerardo, S C Yoder, D M Citron, et al.
Journal of Clinical Microbiology|July 5, 2007
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agentsDiane M Citron, Ellie J C Goldstein, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2009
Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosaEllie J C Goldstein, Diane M Citron, Victoria Peraino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2016
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care HospitalsJennifer H Han, Ellie J C Goldstein, Jacqueleen Wise, et al.
Pageof 24

Showing results (131-140 of 234) with videos related to

Sort By:
Pageof 24
Msystems|March 17, 2021
Patient and Microbial Genomic Factors Associated with Carbapenem-Resistant Klebsiella pneumoniae Extraintestinal Colonization and InfectionZena Lapp, Jennifer H Han, Jenna Wiens, et al.
The American Journal of Gastroenterology|January 12, 2022
Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?Lynne V McFarland, Ravina Kullar, Stuart Johnson, et al.
International Journal of Antimicrobial Agents|August 1, 2006
In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodensC Vreni Merriam, Diane M Citron, Kerin L Tyrrell, et al.
Journal of Clinical Microbiology|June 28, 2013
Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samplesKerin L Tyrrell, Diane M Citron, Eliza S Leoncio, et al.
Anaerobe|October 8, 2016
The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenemsEllie J C Goldstein, Diane M Citron, Kerin L Tyrrell, et al.
Journal of Medical Microbiology|March 20, 2008
Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureusEllie J C Goldstein, Diane M Citron, Yumi A Warren, et al.
Oral Microbiology and Immunology|October 2, 2002
Sequence conservation and distribution of the fusobacterial immunosuppressive protein gene, fipAS Hunt Gerardo, S C Yoder, D M Citron, et al.
Journal of Clinical Microbiology|July 5, 2007
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agentsDiane M Citron, Ellie J C Goldstein, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2009
Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosaEllie J C Goldstein, Diane M Citron, Victoria Peraino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2016
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care HospitalsJennifer H Han, Ellie J C Goldstein, Jacqueleen Wise, et al.
Pageof 24